Surgical treatment to increase the success rate of multidrug-resistant tuberculosis

Abstract

OBJECTIVE: Mycobacterium tuberculosis infects more than one-third of the world’s population and causes an estimated 2–3 million deaths annually. The medical treatment of multidrug-resistant tuberculosis (MDR-TB) can cure 50–75 % of cases. The median prevalence of new MDR-TB cases is 1.1%, while that of previously treated cases is 7%. METHODS: We carried out a retrospective study on 45 patients with MDR-TB who underwent surgical resection at the Leon Daniell